טאזופיפ 2.25 ג'

Nazione: Israele

Lingua: ebraico

Fonte: Ministry of Health

Principio attivo:

PIPERACILLIN AS SODIUM 2000 MG; TAZOBACTAM AS SODIUM 250 MG

Commercializzato da:

PERRIGO ISRAEL AGENCIES LTD

Codice ATC:

J01CR05

Forma farmaceutica:

POWDER FOR SOLUTION FOR INJECTION

Via di somministrazione:

I.V

Prodotto da:

HOSPIRA HEALTHCARE INDIA PVT. LTD

Gruppo terapeutico:

PIPERACILLIN AND ENZYME INHIBITOR

Indicazioni terapeutiche:

Antibiotic for the treatment of systemic and/or local bacterial infections caused by susceptible organisms. Tazo-Pip in combination with an aminoglycoside, is indicated for suspected bacterial infections in neutropenic adults or children. Appendicitis complicated by rupture with peritonitis and/or abscess formation in children aged 2-12 years.

Data dell'autorizzazione:

2012-06-01